G1 Therapeutics Garners $12,500,000 Series A Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=38eb2c44-ad8b-4e56-b565-dc8a50182cd4
Date
10/16/2013
Company Name
G1 Therapeutics
Mailing Address
450 West Drive Chapel Hill, NC 27599 USA
Company Description
G1 Therapeutics is working to commercialize a proprietary small molecule-based approach to protect the bone marrow from damage due to chemotherapy or radiation.
Website
http://www.g1therapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$12,500,000
Transaction Round
Series A
Proceeds Purposes
We are excited to have MedImmune Ventures partner with Hatteras and G1 in order to accelerate the lead candidate toward clinical testing.
M&A Terms
Venture Investor
Venture Investor
Venture Investor
Venture Investor